TipRanks
Palisade Bio (DE:7NS0)
FRANKFURT:7NS0
Germany Market
7NS0
Palisade Bio
RESEARCH TOOLSreports

Palisade Bio (7NS0) Ratios

1 Followers

Palisade Bio Ratios

DE:7NS0's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, DE:7NS0's free cash flow was decreased by $ and operating cash flow was $-21.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 24.26 28.95 3.24 5.15 4.89
Quick Ratio
 24.26 28.95 3.24 5.15 4.89
Cash Ratio
 23.86 28.77 3.03 4.81 4.11
Solvency Ratio
 -5.74 -3.38 -4.26 -4.49 -4.34
Operating Cash Flow Ratio
 -3.47 -2.34 -3.77 -4.31 -4.44
Short-Term Operating Cash Flow Coverage
 0.00 -152.77 -154.34 -70.46 -151.82
Net Current Asset Value
$ 121.69M$ 129.26M$ 7.11M$ 10.59M$ 11.45M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 <0.01 0.02 0.03 0.03
Debt-to-Equity Ratio
 0.00 <0.01 0.02 0.03 0.03
Debt-to-Capital Ratio
 0.00 <0.01 0.02 0.03 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.05 1.04 1.45 1.24 1.26
Debt Service Coverage Ratio
 -5.54K -207.01 -158.49 -70.99 -141.03
Interest Coverage Ratio
 -5.89K -1.81K -1.24K -871.33 -1.21K
Debt to Market Cap
 0.00 <0.01 0.03 0.04 <0.01
Interest Debt Per Share
 <0.01 <0.01 0.13 0.84 0.47
Net Debt to EBITDA
 3.77 7.95 0.67 0.98 0.84
Profitability Margins
Gross Profit Margin
100.00%0.00%0.00%100.00%0.00%
EBIT Margin
-6644.00%0.00%0.00%-4914.00%0.00%
EBITDA Margin
-6643.80%0.00%0.00%-4912.40%0.00%
Operating Profit Margin
-7069.80%0.00%0.00%-5228.00%0.00%
Pretax Profit Margin
-6388.20%0.00%0.00%-4920.00%0.00%
Net Profit Margin
-6388.20%0.00%0.00%-4920.00%0.00%
Continuous Operations Profit Margin
-6388.20%0.00%0.00%-4920.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
90.36%92.94%97.17%94.11%90.71%
Return on Assets (ROA)
-25.09%-12.49%-132.70%-87.53%-90.47%
Return on Equity (ROE)
-33.47%-12.97%-192.71%-108.72%-114.27%
Return on Capital Employed (ROCE)
-28.96%-13.92%-194.39%-113.99%-123.29%
Return on Invested Capital (ROIC)
-28.96%-13.91%-190.18%-111.28%-121.45%
Return on Tangible Assets
-25.09%-12.49%-132.70%-87.53%-90.47%
Earnings Yield
-8.94%-12.83%-617.96%-304.78%-20.77%
Efficiency Ratios
Receivables Turnover
 1.00 0.00 0.00 1.69 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 1.20 0.00
Asset Turnover
 <0.01 0.00 0.00 0.02 0.00
Working Capital Turnover Ratio
 <0.01 0.00 0.00 0.02 0.00
Cash Conversion Cycle
 365.00 0.00 0.00 216.08 0.00
Days of Sales Outstanding
 365.00 0.00 0.00 216.08 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 365.00 0.00 0.00 216.08 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.09 -0.19 -8.61 -24.41 -15.18
Free Cash Flow Per Share
 -0.09 -0.19 -8.61 -24.42 -15.19
CapEx Per Share
 0.00 0.00 0.00 <0.01 0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 -2.78K -1.34K
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -2.78K -1.34K
Operating Cash Flow Coverage Ratio
 0.00 -152.77 -72.15 -30.17 -33.07
Operating Cash Flow to Sales Ratio
 -36.38 0.00 0.00 -44.53 0.00
Free Cash Flow Yield
-6.20%-8.29%-521.87%-275.96%-19.48%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.18 -7.83 -0.16 -0.33 -4.81
Price-to-Sales (P/S) Ratio
 586.70 0.00 0.00 16.14 0.00
Price-to-Book (P/B) Ratio
 2.93 1.01 0.31 0.36 5.50
Price-to-Free Cash Flow (P/FCF) Ratio
 -16.13 -12.06 -0.19 -0.36 -5.13
Price-to-Operating Cash Flow Ratio
 -19.64 -12.06 -0.19 -0.36 -5.14
Price-to-Earnings Growth (PEG) Ratio
 -0.01 0.08 <0.01 >-0.01 0.05
Price-to-Fair Value
 2.93 1.01 0.31 0.36 5.50
Enterprise Value Multiple
 -5.06 0.15 0.51 0.65 -3.98
Enterprise Value
 168.18M -2.49M -7.32M -8.03M 56.67M
EV to EBITDA
 -5.06 0.15 0.51 0.65 -3.98
EV to Sales
 336.36 0.00 0.00 -32.11 0.00
EV to Free Cash Flow
 -9.25 0.23 0.60 0.72 -4.24
EV to Operating Cash Flow
 -9.25 0.23 0.60 0.72 -4.24
Tangible Book Value Per Share
 0.58 2.32 5.29 24.81 14.18
Shareholders’ Equity Per Share
 0.58 2.32 5.29 24.81 14.18
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 0.00 0.00 0.55 0.00
Net Income Per Share
 -0.15 -0.30 -10.20 -26.97 -16.20
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.96 1.00 1.00 1.00 1.00
Research & Development to Revenue
 42.73 0.00 0.00 27.57 0.00
SG&A to Revenue
 28.97 0.00 0.00 24.81 0.00
Stock-Based Compensation to Revenue
 25.80 0.00 0.00 2.50 0.00
Income Quality
 0.57 0.65 0.84 0.91 0.94
Currency in USD